Frequent Migraines in Children: Causes, Triggers, and Management

Pediatric migraine affects ~10% of school-aged children and ~20% of adolescents. Chronic migraine (≥15 headache days/month, ≥8 migraine days) occurs in 1–2% of adolescents. Early diagnosis and multimodal management improve outcomes.

Etiology & Risk Factors

  • Genetics: 70–90% have affected first-degree relative; polygenic (CACNA1A, ATP1A2, SCN1A for hemiplegic; common variants for typical)
  • Sex: Prepubertal: equal; postpubertal: female predominance (3:1)
  • Comorbidities: Anxiety, depression, sleep disorders, epilepsy, motion sickness, colic history

Common Triggers (Individualized)

  • Sleep: Irregular schedule, insufficient sleep, oversleeping
  • Dietary: Skipped meals, dehydration, caffeine (withdrawal/excess), aged cheese, processed meats (nitrates), MSG, artificial sweeteners, chocolate (variable)
  • Environmental: Bright light, loud noise, strong odors, weather changes, screen time
  • Psychological: Stress (academic, social), anxiety, excitement
  • Hormonal: Menarche, menstrual cycle (catamenial migraine)
  • Physical: Exertion, head trauma, illness

Diagnostic Approach

  • History: ICHD-3 criteria (≥5 attacks, 2–72 hr, ≥2 features: unilateral, pulsating, moderate-severe, aggravated by activity; + nausea/photophobia/phonophobia)
  • Pediatric variants: Shorter duration (1–72 hr), bilateral common, GI symptoms prominent
  • Red flags (neuroimaging indicated): Thunderclap onset, focal neuro signs, papilledema, progressive pattern, age <3, occipital pain, Valsalva-aggravated, systemic signs
  • Diary: Headache calendar (frequency, duration, severity, triggers, meds, response)

Management: Tiered Approach

Tier 1: Lifestyle & Non-Pharmacologic (Foundation)

  • Regular sleep/wake, hydration, meals (no skipping)
  • Trigger identification/avoidance (diary-guided)
  • Stress management: CBT, biofeedback, relaxation, mindfulness
  • Regular aerobic exercise
  • Screen time limits, blue light reduction

Tier 2: Acute Treatment (At Onset)

  • NSAIDs: Ibuprofen 10 mg/kg (max 400–600 mg) — first-line
  • Acetaminophen: 15 mg/kg — alternative
  • Triptans (FDA-approved ≥6–12 years): Rizatriptan ODT ≥6 yr, Almotriptan ≥12 yr, Sumatriptan nasal ≥12 yr, Zolmitriptan nasal ≥12 yr
  • Antiemetics: Prochlorperazine, ondansetron (if nausea prominent)
  • Early treatment + rest in dark, quiet room
  • Limit: <2–3 days/week to avoid medication-overuse headache

Tier 3: Preventive Therapy (If ≥4 days/month disability)

  • First-line (evidence-based): Topiramate (2–4 mg/kg/day), Propranolol, Amitriptyline, Cyproheptadine (younger kids)
  • Newer: CGRP mAbs (erenumab ≥6 yr, galcanezumab ≥6 yr — FDA approved pediatric)
  • Nutraceuticals: Magnesium (glycinate/citrate 9 mg/kg), Riboflavin 400 mg, CoQ10 — low risk, modest evidence
  • CBT + biofeedback: Strong evidence for pediatric migraine

When to Refer

  • Red flags, treatment failure, chronic migraine, hemiplegic/basilar features, comorbid psychiatric complexity
  • Pediatric neurologist / headache specialist

Migraine - Related Articles